Seamus Mulligan serves as Executive at Jazz Pharmaceuticals plc, where they oversee executive responsibilities. Since joining the company, Seamus Mulligan has executed 104 insider transactions totaling $313.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 9, 2012 involved receiving (via award) 17,500 shares valued at $0.
Seamus Mulligan currently holds 1,179,613 shares of Jazz Pharmaceuticals plc (JAZZ), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Seamus Mulligan has been a net seller of JAZZ stock. They have purchased $12.8M and sold $300.4M worth of shares.
Seamus Mulligan's most recent insider trade was on Aug 9, 2012, when they sold 17,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 9, 2012 | JAZZ | $0 | Gift | 864,954 | $N/A | Discretionary |
| Mar 9, 2012 | JAZZ | $99.1M | Sale | 2,000,000 | $49.56 | Discretionary |